Skip to main content

Topic

Product Liability

2,986 published works

  1. Drug & Device Law

    Dismissal of Negligent Undertaking Claim in Massachusetts

    By Eric Hudson

    Today’s opinion, Digan v. Luxco, Inc., 2026 U.S. Dist. LEXIS 209391 (D. Mass. Sept. 16, 2026), arises from the bad combination of an open flame, a fraternity party, and Everclear…

  2. Stritmatter Law Blog

    Parents File Lawsuit Against Amazon for Dangerous Laser Pointer

    By Publisher

    For Immediate Release An Idaho family has retained Stritmatter Law to file a lawsuit against Amazon and the manufacturers of a dangerous laser pointer sold on the site. The Lennoos…

  3. Product Perspective: Complex Tort & Product Law

    Autonomous Vehicles: The Road Ahead for Product Liability

    By Kate Dickenson, Ciara Harper, Luke Hemmerla

    The U.S. Department of Transportation estimates that millions of Americans are injured in motor vehicle crashes annually.1 In just 2025, an estimated 36,640 Americans died as a result of a…

  4. Drug & Device Law

    Lost In Translation

    By Lisa Baird

    Having clerked for a federal district judge and cut our litigation teeth in MDLs, federal court practice has burrowed deep.  When we think of procedural issues, our brains reflexively think…

  5. Drug & Device Law

    N.D. Cal. Dismisses Device Claim for Lack of Defect

    By Stephen McConnell

    Perez v. Apyx Medical Corp., 2026 WL 2691359 (N.D. Cal. Sept. 14, 2026), is a product liability suit alleging misrepresentations about off-label use of a company’s cosmetic surgery §510(k) device.…

  6. Drug Injury Watch

    NAION News Reports: GLP-1 Side Effect Harms Vision, Eyes

    By Tom Lamb

    Ozempic, Wegovy, Mounjaro, Zepbound Associated With Loss of Eyesight (Posted by Tom Lamb at Drug Injury Watch) Non-arteritic anterior ischemic optic neuropathy (NAION) is a GLP-1 side effect that harms vision by causing…

  7. Marler Blog

    Target Denies Responsibility, But We Are Doing All We Can to Protect Babies Against the Next Botulism Outbreak

    By Bill Marler

    Last Friday, Target told a federal court that it had no duty to ask a single question about the infant formula it sold – even in the middle of a national infant…

  8. Drug & Device Law

    Let the Science Do the Science – S.D.N.Y Torches Every Benzene Theory in OTC Acne MDL

    By Michelle Yeary

    We’ve written a lot of benzene posts on this blog over the years, and most of them share a common thread. Plaintiffs find a chemical decomposition byproduct nobody put on…

  9. Drug & Device Law

    California’s Recent Gilead Decision Explains Why “Pre-Approval” Tort Claims Don’t, and Shouldn’t, Exist

    By Bexis

    Nearly a decade ago we published the blogpost “Pre-Approval Design Defects – No Such Thing.”  As we discussed, “pre-approval” design (later joined by warning) claims were a transparent preemption dodge. …

  10. The State AG Report

    Abbott Laboratories Agrees to Pay Over $384 Million Settlement Over Powder Infant Formula Allegations

    By Cozen O'Connor

    The post Abbott Laboratories Agrees to Pay Over $384 Million Settlement Over Powder Infant Formula Allegations appeared first on The State AG Report.